3.38
0.16 (4.97%)
| Previous Close | 3.22 |
| Open | 3.24 |
| Volume | 8,429 |
| Avg. Volume (3M) | 34,470 |
| Market Cap | 8,604,669 |
| Price / Sales | 1.28 |
| Price / Book | 1.47 |
| 52 Weeks Range | |
| Earnings Date | 26 Aug 2025 - 1 Sep 2025 |
| Profit Margin | -85.42% |
| Operating Margin (TTM) | -108.13% |
| Diluted EPS (TTM) | -2.16 |
| Quarterly Revenue Growth (YOY) | 10.00% |
| Total Debt/Equity (MRQ) | 9.81% |
| Current Ratio (MRQ) | 3.76 |
| Operating Cash Flow (TTM) | -4.22 M |
| Levered Free Cash Flow (TTM) | -2.29 M |
| Return on Assets (TTM) | -35.99% |
| Return on Equity (TTM) | -72.70% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | Biomerica, Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | -0.88 |
|
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 9.74% |
| % Held by Institutions | 5.80% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Bulltick Wealth Management, Llc | 31 Mar 2025 | 17,144 |
| Hollencrest Capital Management | 31 Mar 2025 | 11,600 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |